Kerna Labs builds foundation models of RNA to unlock the full potential of mRNA as a therapeutic modality (beyond vaccines). Their platform solves critical bottlenecks in mRNA payload design and delivery, including: potency and protein output, tissue specificity, half-life, and manufacturability.
Their AI-powered approach allows them to optimize mRNA like never before - meaning they can tackle previously un- or under-treated diseases. StoryHouse is evaluating the Series A.
RAW NOTES: Good brief conversation with Amit Deshwar, co-founder of Kerna Labs. According to Amit, data has progressed well, and they feel ready for a good story with Series A (or next financing). Amit says they have nearly finalized all their investment materials in the data room and are just...
Source: Meeting Notes recnM1tDPtlaBKdbz